PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIRA.L Share News (MIRA)

  • There is currently no data for MIRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Mirada slides on plan to leave AIM and return to private ownership

Thu, 18th May 2023 17:27

(Alliance News) - Mirada PLC on Thursday announced plans to cease trading on AIM and return to private ownership, sending shares plummeting 61%.

The Surrey, England-based provider of software for digital television said after a review of the benefits and drawbacks of retaining the AIM listing, the firm concluded the proposals are in the best interests of the company and shareholders as a whole.

Mirada explained the review highlighted the impact of the concentration of shares owned by one major shareholder, the inability of the company to attract material new investment from third party equity investors, the public market share trading and valuation volatility of the company and the increasing costs of maintaining a public quotation.

The proposals require the backing of at least 75% of shareholders, but majority investor Kaptungs, which holds 87% of Mirada stock, is backing the plans.

The expected last day of dealings in Mirada shares is June 16.

Mirada also updated investors on current trading, reporting business levels for the 12 months to March 31 were similar to the year prior.

Revenue for the financial year is expected to be around USD10.7 million, down marginally from USD11.0 million a year before, with adjusted earnings before interest, taxation, depreciation and amortisation expected to be around USD1.5 million compared to USD1.6 million.

Net debt has increased from USD8.59 million to USD9.75 million in the period, and Mirada said it "continues to be reliant on the financial support of Kaptungs."

But the company struck an upbeat note for future prospects.

"With more than 30 content provider integrations, growing demand for Mirada's Android TV product across its end markets and market activity at pre-Covid levels, the group remains well positioned to continue to benefit from the strong current pipeline, especially in the Latin America region."

Shares in Mirada fell 61% to 7.50 pence in London on Thursday.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Sep 2014 05:26

UK AGM, EGM Calendar - Week Ahead

Read more
23 Sep 2014 15:06

UK AGM, EGM Calendar - Week Ahead

Read more
23 Sep 2014 05:21

UK AGM, EGM Calendar - Week Ahead

Read more
22 Sep 2014 15:09

UK AGM, EGM Calendar - Week Ahead

Read more
22 Sep 2014 05:20

UK AGM, EGM Calendar - Week Ahead

Read more
19 Sep 2014 15:09

UK AGM, EGM Calendar - Week Ahead

Read more
19 Sep 2014 05:25

UK AGM, EGM Calendar - Week Ahead

Read more
18 Sep 2014 15:23

UK AGM, EGM Calendar - Week Ahead

Read more
18 Sep 2014 09:00

Mirada Inks New Supplementary Contract With Latin American Customer

Read more
18 Sep 2014 05:23

UK AGM, EGM Calendar - Week Ahead

Read more
17 Sep 2014 15:01

UK AGM, EGM Calendar - Week Ahead

Read more
12 Aug 2014 10:27

Mirada Swings To Annual Profit; Confident In Outlook

Read more
7 Jul 2014 07:03

Mirada To Raise GBP3.5 Million In Placing, Ramps Up After Contract Win

Read more
29 May 2014 15:54

Spirent Comms Chairman adds £30,358-worth of shares to stake

The Non-Executive Chairman of Spirent Communications has purchased £30,358-worth of shares in the FTSE 250-listed technology group. Alexander Walker acquired 30,000 shares at 101.19p each. He now holds a total of 213,014 shares. The deal comes around a month after the company delivered an impr

Read more
19 May 2014 13:00

UK MIDDAY BRIEFING: AstraZeneca Rejects Pfizer's Final Bid

LONDON (Alliance News) - AstraZeneca Monday rejected a final GBP69 billion takeover proposal from Pfizer Inc, potentially ending the US company's interest in its British rival for the time being.

Pfizer has pledged not to go direct to AstraZeneca's shareholders with

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.